Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
化脓性汗腺炎合并隐匿性关节炎

化脓性汗腺炎合并隐匿性关节炎

一篇来自德国的报告

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
Jun 13, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
化脓性汗腺炎合并隐匿性关节炎
Share

AI generated Contemporary Chinese Translation (当代中文翻译)

对于身处皮肤病学和风湿病学交叉领域的临床医生而言,炎症性皮肤病与关节受累之间的关联早已明确,其中最显著的例子是银屑病-银屑病关节炎谱系。现在,新的数据强烈表明,化脓性汗腺炎(HS)与炎性关节炎也存在类似的关联,尽管这种关联在临床上不那么明显。一项近期研究揭示了HS中存在隐匿性关节病的有力证据,而HLA-B27的极高患病率则凸显了这一点。

在一个出现关节痛的HS患者队列中,竟有高达76%的患者被发现HLA-B27呈阳性。这一发现本身就是一个重要信号,指向一种潜在的、类似脊柱关节病的表型。然而,其临床表现却具有欺骗性的良性特征;在这些患者中,正式的关节肿胀计数仅有12%为阳性,中位数则为零。这种差异凸…

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share